FindTrial
Sign In

Targeting Ovarian Cancer Metastases: AI-based Precise Segmentation and Intelligent and Trustworthy Generation of Structured Reports

Targeting Ovarian Cancer Metastases: AI-based Precise Segmentation and Intelligent and Trustworthy Generation of Structured Reports

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106668
Enrollment
Unknown
Registered
2025-07-28
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epithelial ovarian cancer

Interventions

Gold Standard:Intraoperative findings and postoperative pathology of the patient
Index test:AI-based Precise Segmentation and Structured Reports targeting Ovarian Cancer Metastases

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Surgical pathology confirmed epithelial ovarian cancer; 2. Abdominal pelvic CT was performed four weeks before surgery, including four phases of images; 3. There are detailed clinicopathological data;

Exclusion criteria

Exclusion criteria: 1. The image quality does not meet the requirements of post-processing analysis; 2. A large amount of ascites obscured the lesions and could not be labeled;

Design outcomes

Primary

MeasureTime frame
The location of the patient's tumor;consistency;—

Countries

China

Contacts

Public ContactYonglan He

Peking Union Medical College Hospital

heyonglan@pumch.cn+86 10 6915 9610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026